# Coherus Oncology, Inc.: Form 8-K, filed Apr 1, 2025

- Company: [Coherus Oncology, Inc.](/companies/chrs.md) (CIK 1512762)
- Form: 8-K
- Filed: 2025-04-01
- Accepted by EDGAR: Apr 1, 2025, 16:10 ET
- Period: 2025-03-31
- Accession: 0001558370-25-004264
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1512762/000155837025004264/chrs-20250331x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1512762/000155837025004264/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1512762/000155837025004264/chrs-20250331x8k.htm

Filed Apr 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-004264. Last ingested by Listed: Oct 29, 2026, 08:11 ET. No prices; not investment advice.